Clinical Trial Update: Pharmacokinetics of Low Dose Raltegravir [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating the pharmacokinetics of low-dose raltegravir in HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections | Phase 2 | Status: COMPLETED